TY - JOUR
T1 - Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications
AU - Byrappa, K.
AU - Ohara, S.
AU - Adschiri, T.
N1 - Funding Information:
This work was supported by a Scientific Research Grant from the Ministry of Education, Science, Sports, and Culture of Japan; Grant-in-Aid for the COE project titled “Giant Molecules and Complex Systems”, Japan; and Department of Science and Technology, Government of India. The authors thank Prof. B. Basavalingu, DOS in Geology, Univ. of Mysore, India for his support in preparing this review.
PY - 2008/2/14
Y1 - 2008/2/14
N2 - Supercritical fluid (SCF) technology has become an important tool of materials processing in the last two decades. Supercritical CO2 and H2O are extensively being used in the preparation of a great variety of nanomaterials. The greatest requirement in the application of nanomaterials is its size and morphology control, which determine the application potential of the nanoparticles, as their properties vary significantly with size. Although significance of SCF technology has been described earlier by various authors, the importance of this technology for the fabrication of inorganic and hybrid nanomaterials in biomedical applications has not been discussed thoroughly. This review presents the nanomaterial preparation systematically using SCF technology with reference to the processing of biomedical materials. The basic principles of each one of the processes have been described in detail giving their merits and perspectives. The actual experimental data and results have been discussed in detail with respect to the selected nanomaterials for biomedical applications. The SCF synthesis of nanoparticles like phosphors, magnetic materials, carbon nanotubes, etc. have been discussed as they have potential applications in bio-imaging, hyperthermia, cancer therapy, neutron capture therapy, targeted drug delivery systems and so on. The more recent approach towards the in situ surface modification, dispersibility, single nanocrystal formation, and morphology control of the nanoparticles has been discussed in detail.
AB - Supercritical fluid (SCF) technology has become an important tool of materials processing in the last two decades. Supercritical CO2 and H2O are extensively being used in the preparation of a great variety of nanomaterials. The greatest requirement in the application of nanomaterials is its size and morphology control, which determine the application potential of the nanoparticles, as their properties vary significantly with size. Although significance of SCF technology has been described earlier by various authors, the importance of this technology for the fabrication of inorganic and hybrid nanomaterials in biomedical applications has not been discussed thoroughly. This review presents the nanomaterial preparation systematically using SCF technology with reference to the processing of biomedical materials. The basic principles of each one of the processes have been described in detail giving their merits and perspectives. The actual experimental data and results have been discussed in detail with respect to the selected nanomaterials for biomedical applications. The SCF synthesis of nanoparticles like phosphors, magnetic materials, carbon nanotubes, etc. have been discussed as they have potential applications in bio-imaging, hyperthermia, cancer therapy, neutron capture therapy, targeted drug delivery systems and so on. The more recent approach towards the in situ surface modification, dispersibility, single nanocrystal formation, and morphology control of the nanoparticles has been discussed in detail.
KW - ASES
KW - Bio-imaging
KW - Drug delivery system
KW - GAS
KW - Hyperthermia
KW - Nanomaterial fabrication
KW - Neutron capture therapy
KW - PGSS
KW - RESS
KW - SCF technology
KW - SEDS
KW - SFEE
KW - Size and morphology control
KW - Supercritical hydrothermal synthesis
KW - Surface modification
UR - http://www.scopus.com/inward/record.url?scp=39149086684&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39149086684&partnerID=8YFLogxK
U2 - 10.1016/j.addr.2007.09.001
DO - 10.1016/j.addr.2007.09.001
M3 - Review article
C2 - 18192071
AN - SCOPUS:39149086684
SN - 0169-409X
VL - 60
SP - 299
EP - 327
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
IS - 3
ER -